Tagmokitug

它莫奇塔单抗

Report date: 2026/04/17 20:02:02

Base Information

Drug NameTagmokitug
Drug Alias NameSRF-114CHS-114
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human
Mechanisms of ActionC-C chemokine receptor type 8 inhibitors
TargetsC-C chemokine receptor type 8
Therapy Area/IndicationsSolid tumoursSquamous Cell Carcinoma of Head and NeckNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesTaiwan
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesSurface Oncology Inc
China Registration ClassN/A

Develop Information

Active CompaniesCoherus Oncology Inc
Inactive CompaniesSurface Oncology Inc
Active IndicationsSolid tumoursSquamous Cell Carcinoma of Head and Neck
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A